JFLLIFEPharmaceuticals

JFL LIFE SCIENCESQuarterly Results & Earnings

8.55
-4.32%
Profit Growth YoY35.86%Latest quarter
Sales Growth YoY-24.30%Latest quarter
Sales CAGR 5Y22.15%5 year compound
Profit CAGR 5Y63.14%5 year compound
📋

Quarterly Performance

YoY Profit Growth+35.86%
🔥 Exceptional growth
YoY Sales Growth-24.30%
🔴 Significant decline
OPM 5Y Average
Operating profit margin
10.19%
EPS Growth 5Y
-14.56%
Interest Coverage
Higher = safer debt servicing
5.40
ROE
11.09%
ROCE
15.81%
💡

Growth Analysis

JFL LIFE SCIENCES reported YoY profit growth of 35.86% and revenue growth of -24.30% in the latest quarter. Double-digit profit growth above 20% is exceptional — indicates strong business momentum. Over 5 years, sales compounded at 22.15% and profits at 63.14% annually. This is above-average growth for Indian listed companies. Consistent growth over 4-8 quarters is more meaningful than any single quarter. Educational data only.

Data from NSE/BSE public filings. Educational purposes only. Bull Run is not SEBI-registered. Not investment advice.